Show simple item record

dc.contributor.authorFukae, Jiro
dc.contributor.authorSato, Shigeto
dc.contributor.authorShiba, Kahori
dc.contributor.authorSato, Ken-ichi
dc.contributor.authorMori, Hideo
dc.contributor.authorMizuno, Yoshikuni
dc.contributor.authorHattori, Nobutaka
dc.contributor.authorSharp, Phillip A.
dc.date.accessioned2015-03-31T15:11:15Z
dc.date.available2015-03-31T15:11:15Z
dc.date.issued2009-01
dc.date.submitted2008-12
dc.identifier.issn00145793
dc.identifier.issn1873-3468
dc.identifier.urihttp://hdl.handle.net/1721.1/96274
dc.description.abstractMutations in parkin gene are responsible for autosomal recessive Parkinson’s disease (ARPD) and its loss-of-function is assumed to affect parkin ubiquitin ligase activity. Accumulation of its substrate may induce dopaminergic neurodegeneration in the substantia nigra (SN) of ARPD. Here, we show that parkin interacts with programmed cell death-2 isoform 1 (PDCD2-1) and promotes its ubiquitination. Furthermore, accumulation of PDCD2-1 was found in the SN of ARPD as well as in sporadic PD, suggesting that common failure of the ubiquitin–proteasome system is associated with neuronal death in both ARPD and sporadic PD.en_US
dc.language.isoen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttp://dx.doi.org/10.1016/j.febslet.2008.12.055en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceElsevieren_US
dc.titleProgrammed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson’s diseaseen_US
dc.typeArticleen_US
dc.identifier.citationFukae, Jiro, Shigeto Sato, Kahori Shiba, Ken-ichi Sato, Hideo Mori, Phillip A Sharp, Yoshikuni Mizuno, and Nobutaka Hattori. “Programmed Cell Death-2 Isoform1 Is Ubiquitinated by Parkin and Increased in the Substantia Nigra of Patients with Autosomal Recessive Parkinson’s Disease.” FEBS Letters 583, no. 3 (February 2009): 521–525. © 2009 Federation of European Biochemical Societies.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorSharp, Phillip A.en_US
dc.relation.journalFEBS Lettersen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsFukae, Jiro; Sato, Shigeto; Shiba, Kahori; Sato, Ken-ichi; Mori, Hideo; Sharp, Phillip A; Mizuno, Yoshikuni; Hattori, Nobutakaen_US
dc.identifier.orcidhttps://orcid.org/0000-0003-1465-1691
mit.licensePUBLISHER_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record